Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMACN68)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
AC1LEF7F; Methanone, (2-methylphenyl)-1H-pyrazol-1-yl-; N-Benzoylpyrazole deriv., 26; SCHEMBL5091107; CHEMBL243419; 2-methylphenyl pyrazolyl ketone; ZINC52093; BDBM23718; MolPort-001-495-866; STK458861; AKOS003267448; MCULE-5548346973; (2-methylphenyl)-pyrazol-1-ylmethanone; ST073761; 312317-26-3; 1-[(2-methylphenyl)carbonyl]-1H-pyrazole; (2-methylphenyl)(1H-pyrazol-1-yl)methanone; SR-01000520970; SR-01000520970-1
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||